Panattoni L, Brown P, Ao T, Webster M, Gladding P. Personalised thienopyridine therapy: the cost effectiveness of genetic testing for CYP2C19 variants to guide treatment in patients with acute coronary syndromes: A New Zealand Evaluation. Pharmacoeconomics. 2012;30:1067–1084.